Signaling Pathways
-
A4057 AUY922 (NVP-AUY922)1 CitationTarget: HSP90Summary: Potent Hsp90 inhibitor
-
A4060 Geldanamycin2 CitationSummary: Hsp90 inhibitor,potent and specific
-
A4061 IPI-504 (Retaspimycin hydrochloride)3 CitationTarget: HSP90Summary: Hsp90 inhibitor,novel, potent,selective
-
A4064 NVP-BEP800Target: HSP90Summary: Oral Hsp90β inhibitor, novel, fully synthetic
-
A4065 PF-04929113 (SNX-5422)Target: HSP90Summary: Hsp90 inhibitor,potent and selective
-
A4135 Tofacitinib (CP-690550) Citrate2 CitationTarget: JAKSummary: Potent JAK inhibitor
-
A4136 TG101348 (SAR302503)2 CitationTarget: FLT3|JAK|c-RETSummary: JAK-2 inhibitor,potent and selective
-
A4138 Tofacitinib (CP-690550,Tasocitinib)1 CitationTarget: JAKSummary: Janus kinase inhibitor
-
A4139 AG-4903 CitationTarget: EGFR|JAKSummary: JAK2/EGFR inhibitor
-
A4148 NVP-BSK805 2HClTarget: JAKSummary: JAK2 inhibitor